The present study was designed to evaluate the beneficial effects of BM-573, a dual TxAS inhibitor and TP receptor antagonist, on the vasodilatory function and blood pressure in ApoE-KO mice at early stage of atherosclerosis. The gene discussed is APOE; the disease is atherosclerosis.